RecallDepth
Class III Terminated

Risedronate Sodium Delayed-release Tablets, 35 mg, Once-a-Week, 1 tablet per blister (NDC 0093-5509-19), packaged in 4 blisters per carton (NDC 0093-5509-44), Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454.

Company
Teva Pharmaceuticals Usa
Recall Initiated
December 1, 2016
Posted
January 25, 2017
Recall Number
D-0431-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
6,800 cartons
Firm Location
North Wales, PA, United States

Reason for Recall

Failed Dissolution Specifications

Distribution

Nationwide in the USA and Puerto Rico

Lot / Code Info

Lot # 34027040A; Exp 10/17

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class III Drug recalls